Singapore Institute for Clinical Sciences (SICS)
New data suggest that metformin administered to pregnant mothers may have unintended effects on the fetus, prompting the need for further assessment of the drug’s risk-benefit ratio.
From the public sector to innovative startups and industry giants, A*STAR scholars are blazing the trail across Singapore’s research ecosystem.
From music streaming technology to COVID-19 tests, A*STAR Assistant Chief Executive (Enterprise) Sze Wee Tan details how the agency is bringing their innovations out of the lab and into the real world.
Through the years, A*STAR has always stood at the forefront of science and technology and innovation. Here’s how A*STAR came to be and what it has in store in the upcoming decades.
Understanding why COVID-19 tends to strike the old but spare the young could inform how to prioritize limited COVID-19 vaccines.
Understanding the impact of antibiotics on both infants and adults could help restore the delicate balance of the gut microbiome.
Apart from the mode of delivery and breastfeeding, genetics and cultural practices could also have a profound impact on the type of bacteria in an infant’s gut.
Early exposure to antibiotics can disrupt an infant’s gut microbiota and predispose them to childhood obesity, finds an observational study.
It’s not only high-sugar diets that we should be concerned about, but also the timing of when we eat them, finds a study in the emerging field of chrononutrition.
Insights into the molecular changes in regenerating liver cells may reveal ways to help patients recover from surgery or disease
A collaboration between A*STAR and Duke-NUS Medical School has gotten closer to freeing some chronic hepatitis B patients from a life of medication
With rhinitis affecting an enormous 40 per cent of Singapore’s population, research in the city state is yielding some very interesting insights into a worldwide problem.